Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease

被引：0
|
作者：
Wu, L. [1 ]
Li, X. [1 ]
Chang, D. [1 ]
Zhang, H. [2 ]
Li, J. [2 ]
Wu, S. [2 ]
Zhang, L. [1 ,3 ]
Chen, M. [1 ]
Zhao, M. [1 ]
机构：
[1] Peking Univ, Hosp 1, Div Renal, Dept Med, Beijing, Peoples R China
[2] North China Univ Sci & Technol, Tangshan, Peoples R China
[3] Peking Univ, Ctr Data Sci Hlth & Med, Beijing, Peoples R China
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2019年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P1808
引用
收藏
页码：143 / 144
页数：2
相关论文
共 50 条
  • [31] Epidermal Growth Factor Receptor: A Potential Therapeutic Target for Diabetic Kidney Disease
    Sheng, Lili
    Bayliss, George
    Zhuang, Shougang
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [32] Urinary monocyte chemoattractant protein-1 in renal disease
    Kim, Min Jeong
    Tam, Frederick W. K.
    CLINICA CHIMICA ACTA, 2011, 412 (23-24) : 2022 - 2030
  • [33] Protein kinase C β inhibitor LY333531 attenuates intercellular adhesion molecule-1 and monocyte chemotactic protein-1 expression in the kidney in diabetic rats
    Wu, Yonggui
    Wu, Guozhong
    Qi, Xiangming
    Lin, Hui
    Qian, Hao
    Shen, Jijia
    Lin, Shantan
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 101 (04) : 335 - 343
  • [34] Association of Monocyte Chemoattractant Protein-1 with Death and Atherosclerotic Events in Chronic Kidney Disease
    Gregg, L. Parker
    Tio, Maria Clarissa
    Li, Xilong
    Adams-Huet, Beverley
    de Lemos, James A.
    Hedayati, S. Susan
    AMERICAN JOURNAL OF NEPHROLOGY, 2018, 47 (06) : 395 - 405
  • [35] Predicting outcome of IgA nephropathy by use of urinary epidermal growth factor: monocyte chemotactic peptide 1 ratio
    Wada, Takashi
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2008, 4 (04): : 184 - 185
  • [36] Predicting outcome of IgA nephropathy by use of urinary epidermal growth factor: monocyte chemotactic peptide 1 ratio
    Takashi Wada
    Nature Clinical Practice Nephrology, 2008, 4 : 184 - 185
  • [37] Monocyte chemotactic protein-1 levels in the vitreons of patients with proliferative vitreoretinopathy
    Mitamura, Y
    Takeuchi, S
    Yamamoto, S
    Yamamoto, T
    Tsukahara, I
    Matsuda, A
    Tagawa, Y
    Mizue, Y
    Nishihira, J
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2002, 46 (02) : 218 - 221
  • [38] Prognostic significance of monocyte chemotactic protein-1 in patients with carotid restenosis
    Linic, I. Strenja
    Kovacevic, M.
    Kovacic, S.
    Sosa, I.
    Trobonjaca, Z.
    Dvornik, S.
    CEREBROVASCULAR DISEASES, 2015, 39 : 38 - 38
  • [39] Plasma soluble adhesion molecule and monocyte chemotactic protein-1 in patients with coronary artery disease
    Yamamoto, H
    Uemura, S
    Tomoda, Y
    Fujimoto, S
    Hashimoto, T
    Dohl, K
    CIRCULATION, 1998, 98 (17) : 106 - 106
  • [40] Plasma levels of the monocyte chemotactic and activating factor monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction
    Matsumori, A
    Furukawa, Y
    Hashimoto, T
    Yoshida, A
    Ono, K
    Shioi, T
    Okada, M
    Iwasaki, A
    Nishio, R
    Matsushima, K
    Sasayama, S
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (01) : 419 - 423
12345